To highlight, we concluded a solid quarter.
As Gavin already elaborated on, we successfully relaunched Zyn, the market-leading brand on all US storefronts, and we maintained our strong gross margin levels.
This allows us to initiate the necessary investment, primarily towards the US market, to lay the foundation for the next growth chapter.
Despite the increased level of investments, our adjusted EBIT remained flat versus the same period last year at 3.5%. On slide eight, let me begin with our serious development.
Like-for-like comparison became even more complex because we have to adjust for 2025 Q3 reported numbers as well.
To make the numbers comparable, in Q3 of 2020 we had Zyn in the US for the full quarter, while in Q3 of 2025 we saw this brand only for 19 days. Our reported sales grew by 1%, excluding the FX impact. Excluding the FX impact, the increase was 3%.
Like-for-like sales growth was 15%. There is no change in the product composition of growth drivers.
The 15% like-for-like growth is mainly driven by nicotine pouches, with Snus remaining in decline, primarily in Sweden, impacting our performance negatively by 5%, partly offset by the emerging segment's contribution to growth of 2%.
The Snus decline accelerated during the quarter. However, on a going forward basis, we expect it to moderate.
Moving to the next slide. Slide nine and going into more details about our like-for-like sales development, you can find the key drivers. The net impact included in the reported sales, driven by the discontinuation of US Zyn tobacco and the closure of some states in the US, was 92 million.
As said before, foreign exchange (FX) also created a headwind. The impact of the foreign exchange movements remained in line with the first half of the year. The depreciation of the Norwegian krone and the US dollar against the Swedish krona has negatively affected reported sales. Zooming into the operational performance, all reporting segments contributed to the like-for-like basis growth segment. The US particularly remained the biggest driver, accounting for 50.54% of the operational growth. The core segment represented 29%, while the emerging segment was 17%.
Moving to slide ten and going down a few lines in the P&L, you can find the long-term quarterly development of Haypp Group gross margin, both in absolute terms and as a percentage of net sales.
Q3's margin levels remained in line with the first half of 2025. Compared to last year, not only in terms of the margin rate but also the key drivers of the increase remained the same year after year. The sustained margin performance is the foundation for the execution of our growth strategy in the US.
This allows us to make the investment required to set the foundation of the next growth chapter.
It's important to highlight that going forward, the return of Zyn is not expected to negatively impact our margin levels.
Sustaining a strong media and insights business will remain important, and the continued development of those products is pivotal. I would like to reaffirm the foundational principles of our business model.
We allocate the value created by our company across our consumers, business partners, and shareholders.
Our ongoing priority is to enhance the value we provide to consumers, which in turn requires us to strengthen the value we generate for our business partners by continuously improving our media and insights offerings.
We are able to deliver greater value and convenience to our consumers, while also driving healthier profit margins over the medium term. On slide 11, you can find an overview of our overhead-based development, which increased to 126 million for the third quarter.
The increase is mainly driven by the development of our US team. We further strengthened our media and insights teams and also invested in activation to increase the online channel and boost brand awareness.
On slide 12, you can find key figures around our profitability. Adjusted EBIT for the third quarter grew by 0.9%, reaching 33.4 million.
The adjusted EBIT margin remained flat at 3.5%. We benefited from the increase in gross margin. However, we invested this increase in overheads and marginally in paid marketing. The increase in depreciation, similar to previous quarters, is driven by the US automation, which we installed in mid-December last year. We maintained our investment in the emerging segment this quarter. The investment amount amounted to 13.1 million SEK and reduced the overall adjusted EBIT of the group by 1.6 percentage points. Adjusted EBIT for the core and growth business was 5.1%, 0.7% higher than the same period last year. Moving into page 13 and core markets, this segment delivered an overall 5% constant currency net sales growth.
The quarter started slowly with some acceleration during the second half.
Behind the sales growth, two completely different dynamics remained. The Nicotine Pouches segment, which accounted for 57% of the volume for our core markets, maintained its growth and consistently gained share. The Snus segment's volume remained in decline, and this decline accelerated in Q3 compared to the first half of the year. The decline was driven by the reduction of the underlying consumer demand. The opposite dynamics in Nicotine Pouches and Snus mean that nicotine pouches are gaining share, which over time helps the overall growth rates of the segment. The changes in the purchasing customer numbers are also showing the different dynamics.
While we are building our nicotine pouch consumer base, the decline in the Swedish snus consumers offsets this. Adjusted EBITDA remained strong for this segment. The 10% Q3 result is 1.3 percentage points above last year. The driver behind the increase is the Media and Insights revenue growth.
On the next slide, slide 14, you can find our growth markets performance.
Net sales excluding currency impact on a like-for-like basis are up by 39%. While all markets increased their sales, we are very pleased with the high double-digit growth rates in the US and the nicotine pouch volume development in the UK. Adjusted EBITDA moved into negative territory, driven by increased investment levels, mainly in the US. In absolute terms, it amounted to -1.4 million.
Secondly, the adjusted EBITDA rate is -0.6%, while profitability is down compared to the same period last year. It is important to note that the gross margin remains stable for the segment.
The overhead increase, mainly driven by the US, negatively impacted the business unit.
On slide 15, in our emerging segment, the sequential sales growth continued, and we are particularly pleased with the Swedish and German market performance. Unfortunately, operating in the UK vape market remained challenging due to the absence of regulatory enforcement across the entire spectrum of market participants.
Haypp Group was and always will be committed to complying with regulation. However, this can create a significant competitive disadvantage in cases where other retailers are not complying in markets and segments where we are market leaders. We can compensate with our weight, but in the UK market, as a challenger, the uneven playing field prohibits us from achieving our ambitions. As you can see on the bottom chart, while Sweden and Germany have maintained their growing trend, this was not the case in the UK. Despite the heavy investments we made both into our consumer offering and our internal capabilities.
This is the reason why we decided that throughout Q4 2025, we are going to discontinue or waive Heat-not-Burn sales in the UK market. On page 16, I would like to highlight 3 or 4 selected KPIs.
The full list of KPIs is available in the appendix of this presentation. Starting with inventory, the increase compared to Q2 is driven by Zyn in the US with a slight reduction in other inventories in other locations. The inventory increase didn't fully translate into an increase in our working capital, driven by improvements in other components. Net debt to adjusted EBITDA ratio remained at 0.4 times. With this, I would like to hand back to Gavin.